Quantcast

Industry news that matters to you.  Learn more

Archives for September 2012

Agilent Technologies, MRM Proteomics Sign Comarketing Agreement to Further Quantitative Proteomics Solutions

Agilent Technologies Inc. (NYSE: A) recently announced that it has entered into a comarketing agreement with MRM Proteomics Inc., a leading provider of advanced protein quantitation, biomarker and proteomic services to the pharmaceutical, biotechnology and diagnostics industries. The agreement will allow both organizations to offer a more complete solution, including kits, hardware and software for proteomics.

Stroke Blood Test that Could Increase Use of Most Effective Treatment Five-fold

Researchers at the University of Geneva (UNIGE), in collaboration with UK company Proteome Sciences plc (PS) describe a simple blood test that could substantially increase the number of patients eligible for highly effective ischaemic stroke therapy in a landmark paper “Blood Glutathione S-Transferase-p (GSTP) as a Time Indicator of Stroke Onset”, published recently in the journal PLoS ONE.

PerkinElmer and TIBCO Software Announce Strategic Alliance for TIBCO Spotfire Data Visualization and Discovery in Certain Scientific Research & Development Markets

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, and TIBCO Software Inc., the provider of TIBCO Spotfire®, a leading analytics and data discovery platform, announced today that they have entered into an exclusive strategic relationship.

Under the terms of this new agreement, PerkinElmer has licensed the exclusive, worldwide rights to the TIBCO Spotfire software platform in certain scientific research and development markets. These markets include basic and preclinical development applications in life sciences as well as R&D, quality assurance and quality control applications in chemical, petrochemical, environmental, food and beverage, consumer products and academia. This alliance will combine the depth and strength of PerkinElmer’s domain knowledge and solutions with the analytical capabilities of TIBCO Spotfire to provide a broader, richer set of analytical solutions for the research market. As a result, PerkinElmer will take responsibility for growing and servicing the TIBCO Spotfire business in these markets.

“How scientists capture and visualize their data through the TIBCO Spotfire platform is fundamental to how scientists conduct their work. Spotfire is a critical data analysis tool for the R&D community and complements PerkinElmer’s informatics offering by adding search and data visualization, which are among the most pressing business requirements of life sciences, diagnostics and environmental laboratories, worldwide,” said Mike Stapleton, general manager of Informatics at PerkinElmer. “Through this strategic relationship, we are very excited to offer scientists a complete package of data generation, data management as well as data analysis and visualization to better harness information for more informed insights and decisions. The interoperability of PerkinElmer’s E-Notebook with the TIBCO Spotfire platform puts all information in one place for our customers.”

One of the greatest challenges for scientists today is the volume and diversity of data they need to capture and analyze to make knowledgeable and informed decisions that impact both research and business intelligence efforts. The TIBCO Spotfire platform helps complete the analysis workflow by adding real time data interpretation to existing data generation and assembly tools. The data visualization tool enables researchers to instantly visualize and share data across an enterprise to uncover opportunities, avoid risks and anticipate trends. This solution can be applied to nearly every type of science and can analyze data from virtually any instrument platform.

“This new relationship is exciting news for research scientists. Our relationship with PerkinElmer will enable a broader community to benefit from the TIBCO Spotfire platform and will expand the range and depth of applications serving the rapidly evolving needs of scientific research,” said Christian Marcazzo, co-head of Global Life Sciences for Spotfire at TIBCO Software Inc.

Source: PerkinElmer

ICON Expands its US and UK Bioanalytical Laboratories

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the expansion of its US and UK bioanalytical facilities to meet the growing demand for biomarker and cell-based assay services.

Parkinson’s Brain Chemistry Changes Now Trackable in Man

KineMed, Inc. announced today the publication of a novel discovery in biomarkers for neurodegenerative diseases from a study funded by The Michael J. Fox Foundation. The absence of meaningful biomarkers has remained a roadblock in the development and clinical application of treatments for neurological disorders. The publication describes in detail a unique class of biomarkers that measure the transport efficiency of key cargo molecules through neurons in the living human brain. Biomarkers of this pathogenically causal process may be used for the development of drugs to treat Parkinson’s disease.